15 February 2023

Field Safety notice regarding medical devices and pharmaceutical products

Reference: CIR-2023-00000018

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Drug Safety-related Labeling Information Updates of Depakine® and Depakine chrono® (Sodium Valproate & sodium valproate+ valproic acid)

Safety Update of Molluscum Contagiosum Associated with the Use of Fingolimod products

Drug Safety-related patient information leaflet (PIL) of CellCept 1000 mg/5 mL Oral Suspension

Field Safety Notice Elecsys Troponin T hs / Elecsys Troponin T hs STAT

Voluntary Recall of Pharmaceutical Product EzriCare & Delsam Pharma Artificial Tears

 

 

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

- Depakine and Depakine chrono 000.pdf:

View Document

Fingolimod00.pdf:

View Document

تقارير السلامة للوسائل الطبية - CellCept 1000 mg-5 mL Oral Suspension --.pdf:

View Document

تقارير السلامة للوسائل الطبية - Elecsys Troponin T hs - Elecsys Troponin T hs STAT ---.pdf:

View Document

تقارير السلامة للوسائل الطبية - EzriCare _ Delsam Pharma Artificial Tears ---.pdf:

View Document